TEVA logo

TEVA Cash from operations

annual CFO:

$1.25B-$121.00M(-8.85%)
December 31, 2024

Summary

  • As of today (May 31, 2025), TEVA annual cash flow from operations is $1.25 billion, with the most recent change of -$121.00 million (-8.85%) on December 31, 2024.
  • During the last 3 years, TEVA annual CFO has risen by +$449.00 million (+56.27%).
  • TEVA annual CFO is now -77.50% below its all-time high of $5.54 billion, reached on December 31, 2015.

Performance

1-year change

-8.85%

3-year change

+56.27%

5-year change

+66.71%

15-year change

-43.96%

TEVA Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.54%
TEVA annual cash flow from operations is higher than 95.54% of companies in Healthcare sector

Range

All-time high

$5.54B
TEVA annual cash flow from operations is currently -77.50% below its historical high of $5.54 billion

3-year low

$798.00M
TEVA annual cash flow from operations is currently +56.27% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
TEVA previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
TEVA next annual earnings announcement has not yet been scheduled

OtherTEVAcash flow metrics

annual CFI

$792.00M
TEVA annual cash flow from investing activities is $792.00 million

annual CFF

-$1.79B
TEVA annual cash flow from financing activities is -$1.79 billion

annual FCF

$749.00M
TEVA annual free cash flow is $749.00 million

annual CAPEX

$498.00M
TEVA annual capital expenditures is $498.00 million

quarterly CFO:

-$105.00M-$680.00M(-118.26%)
March 31, 2025

Summary

  • As of today (May 31, 2025), TEVA quarterly cash flow from operations is -$105.00 million, with the most recent change of -$680.00 million (-118.26%) on March 31, 2025.
  • Over the past year, TEVA quarterly CFO has increased by +$19.00 million (+15.32%).
  • TEVA quarterly CFO is now -105.99% below its all-time high of $1.75 billion, reached on December 31, 2014.

Performance

3-month change

-118.26%

1-year change

+15.32%

3-year change

-114.29%

5-year change

-134.43%

TEVA quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

2.43%
TEVA quarterly cash flow from operations is higher than 2.43% of companies in Healthcare sector

Range

All-time high

$1.75B
TEVA quarterly cash flow from operations is currently -105.99% below its historical high of $1.75 billion

3-year low

-$145.00M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
TEVA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 31, 2025
TEVA next earnings announcement is scheduled for Jul 31, 2025

OtherTEVAcash flow metrics

quarterly CFI

$201.00M
TEVA quarterly cash flow from investing activities is $201.00 million

quarterly CFF

-$1.74B
TEVA quarterly cash flow from financing activities is -$1.74 billion

quarterly FCF

-$232.00M
TEVA quarterly free cash flow is -$232.00 million

quarterly CAPEX

$127.00M
TEVA quarterly capital expenditures is $127.00 million

TTM CFO:

$1.27B+$19.00M(+1.52%)
March 31, 2025

Summary

  • As of today (May 31, 2025), TEVA TTM cash flow from operations is $1.27 billion, with the most recent change of +$19.00 million (+1.52%) on March 31, 2025.
  • Over the past year, TEVA TTM CFO has dropped by -$123.00 million (-8.86%).
  • TEVA TTM CFO is now -78.94% below its all-time high of $6.01 billion, reached on June 30, 2015.

Performance

3-month change

+1.52%

1-year change

-8.86%

3-year change

+9.71%

5-year change

+34.54%

TEVA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.49%
TEVA TTM cash flow from operations is higher than 95.49% of companies in Healthcare sector

Range

All-time high

$6.01B
TEVA TTM cash flow from operations is currently -78.94% below its historical high of $6.01 billion

3-year low

$1.06B
TEVA TTM cash flow from operations is currently +19.55% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
TEVA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 31, 2025
TEVA next earnings announcement is scheduled for Jul 31, 2025

OtherTEVAcash flow metrics

TTM CFI

$849.00M
TEVA TTM cash flow from investing activities is $849.00 million

TTM CFF

-$3.38B
TEVA TTM cash flow from financing activities is -$3.38 billion

TTM FCF

$765.00M
TEVA TTM free cash flow is $765.00 million

TTM CAPEX

$501.00M
TEVA TTM capital expenditures is $501.00 million

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TEVA Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.8%+15.3%-8.9%
3 y3 years+56.3%-114.3%+9.7%
5 y5 years+66.7%-134.4%+34.5%

TEVA Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.6%+56.3%-108.9%+27.6%-31.8%+19.6%
5 y5-year-21.6%+66.7%-108.9%+74.1%-31.8%+180.7%
alltimeall time-77.5%>+9999.0%-106.0%+74.1%-78.9%+1355.6%

TEVA Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$105.00M(-118.3%)
$1.27B(+1.5%)
Dec 2024
$1.25B(-8.8%)
$575.00M(-17.0%)
$1.25B(-32.8%)
Sep 2024
-
$693.00M(+572.8%)
$1.86B(+58.9%)
Jun 2024
-
$103.00M(-183.1%)
$1.17B(-15.9%)
Mar 2024
-
-$124.00M(-110.5%)
$1.39B(+1.5%)
Dec 2023
$1.37B(-14.0%)
$1.18B(>+9900.0%)
$1.37B(+18.2%)
Sep 2023
-
$5.00M(-98.5%)
$1.16B(-31.7%)
Jun 2023
-
$324.00M(-323.4%)
$1.70B(+13.5%)
Mar 2023
-
-$145.00M(-114.9%)
$1.49B(-6.0%)
Dec 2022
$1.59B(+99.2%)
$973.00M(+79.2%)
$1.59B(+48.2%)
Sep 2022
-
$543.00M(+341.5%)
$1.07B(+1.3%)
Jun 2022
-
$123.00M(-351.0%)
$1.06B(-8.2%)
Mar 2022
-
-$49.00M(-110.7%)
$1.15B(+44.6%)
Dec 2021
$798.00M(-34.4%)
$456.00M(-13.8%)
$798.00M(+18.6%)
Sep 2021
-
$529.00M(+142.7%)
$673.00M(+49.2%)
Jun 2021
-
$218.00M(-153.8%)
$451.00M(-10.9%)
Mar 2021
-
-$405.00M(-222.4%)
$506.00M(-58.4%)
Dec 2020
$1.22B(+62.6%)
$331.00M(+7.8%)
$1.22B(-14.5%)
Sep 2020
-
$307.00M(+12.5%)
$1.42B(-1.2%)
Jun 2020
-
$273.00M(-10.5%)
$1.44B(+53.1%)
Mar 2020
-
$305.00M(-43.3%)
$941.00M(+25.8%)
Dec 2019
$748.00M(-69.4%)
$538.00M(+65.5%)
$748.00M(+29.6%)
Sep 2019
-
$325.00M(-243.2%)
$577.00M(-14.3%)
Jun 2019
-
-$227.00M(-302.7%)
$673.00M(-36.6%)
Mar 2019
-
$112.00M(-69.5%)
$1.06B(-56.6%)
Dec 2018
$2.45B(+9.9%)
$367.00M(-12.8%)
$2.45B(-16.7%)
Sep 2018
-
$421.00M(+159.9%)
$2.94B(-11.3%)
Jun 2018
-
$162.00M(-89.2%)
$3.31B(-7.6%)
Mar 2018
-
$1.50B(+74.2%)
$3.58B(+61.1%)
Dec 2017
$2.23B(-42.8%)
$859.00M(+8.1%)
$2.23B(+52.8%)
Sep 2017
-
$795.00M(+82.8%)
$1.46B(-31.4%)
Jun 2017
-
$435.00M(+219.9%)
$2.12B(-19.9%)
Mar 2017
-
$136.00M(+51.1%)
$2.65B(-31.9%)
Dec 2016
$3.89B(-29.8%)
$90.00M(-93.8%)
$3.89B(-28.2%)
Sep 2016
-
$1.46B(+51.7%)
$5.42B(+7.3%)
Jun 2016
-
$963.00M(-30.0%)
$5.05B(-9.3%)
Mar 2016
-
$1.38B(-14.8%)
$5.56B(+0.4%)
Dec 2015
$5.54B(+8.1%)
$1.61B(+47.8%)
$5.54B(-2.4%)
Sep 2015
-
$1.09B(-26.1%)
$5.68B(-5.5%)
Jun 2015
-
$1.48B(+9.3%)
$6.01B(+7.6%)
Mar 2015
-
$1.35B(-22.7%)
$5.58B(+8.9%)
Dec 2014
$5.13B(+58.4%)
$1.75B(+23.0%)
$5.13B(+22.3%)
Sep 2014
-
$1.42B(+35.2%)
$4.19B(+30.5%)
Jun 2014
-
$1.05B(+17.3%)
$3.21B(+5.9%)
Mar 2014
-
$898.00M(+10.0%)
$3.03B(-6.3%)
Dec 2013
$3.24B(-29.2%)
$816.00M(+83.8%)
$3.24B(-19.0%)
Sep 2013
-
$444.00M(-49.3%)
$4.00B(-13.1%)
Jun 2013
-
$875.00M(-20.6%)
$4.60B(-6.4%)
Mar 2013
-
$1.10B(-30.1%)
$4.92B(+7.6%)
Dec 2012
$4.57B(+10.6%)
$1.58B(+50.5%)
$4.57B(+3.4%)
Sep 2012
-
$1.05B(-12.0%)
$4.42B(+14.7%)
Jun 2012
-
$1.19B(+57.5%)
$3.86B(-3.3%)
Mar 2012
-
$756.00M(-47.1%)
$3.99B(-3.5%)
DateAnnualQuarterlyTTM
Dec 2011
$4.13B(-0.0%)
$1.43B(+196.3%)
$4.13B(+8.6%)
Sep 2011
-
$482.00M(-63.6%)
$3.81B(-15.8%)
Jun 2011
-
$1.32B(+47.1%)
$4.52B(+8.9%)
Mar 2011
-
$900.00M(-18.3%)
$4.15B(+0.3%)
Dec 2010
$4.14B(+22.6%)
$1.10B(-7.7%)
$4.14B(+3.6%)
Sep 2010
-
$1.19B(+25.2%)
$3.99B(+4.4%)
Jun 2010
-
$954.00M(+7.7%)
$3.82B(+8.4%)
Mar 2010
-
$886.00M(-7.4%)
$3.53B(+4.5%)
Dec 2009
$3.37B(+4.4%)
$957.00M(-6.6%)
$3.37B(-0.4%)
Sep 2009
-
$1.02B(+55.8%)
$3.38B(+10.3%)
Jun 2009
-
$658.00M(-10.2%)
$3.07B(-4.6%)
Mar 2009
-
$733.00M(-24.4%)
$3.22B(-0.4%)
Dec 2008
$3.23B(+78.2%)
$969.00M(+36.5%)
$3.23B(+15.1%)
Sep 2008
-
$710.00M(-11.9%)
$2.81B(+15.6%)
Jun 2008
-
$806.00M(+8.0%)
$2.43B(+17.9%)
Mar 2008
-
$746.00M(+36.9%)
$2.06B(+13.6%)
Dec 2007
$1.81B(-11.9%)
$545.00M(+64.2%)
$1.81B(-10.8%)
Sep 2007
-
$332.00M(-24.0%)
$2.03B(-18.5%)
Jun 2007
-
$437.00M(-12.4%)
$2.49B(+9.9%)
Mar 2007
-
$499.00M(-34.7%)
$2.27B(+10.3%)
Dec 2006
$2.06B(+50.2%)
$764.40M(-3.6%)
$2.06B(+32.5%)
Sep 2006
-
$792.80M(+272.6%)
$1.55B(+35.6%)
Jun 2006
-
$212.80M(-26.1%)
$1.15B(-15.5%)
Mar 2006
-
$288.00M(+11.2%)
$1.36B(-1.1%)
Dec 2005
$1.37B(+10.0%)
$259.10M(-32.8%)
$1.37B(-8.4%)
Sep 2005
-
$385.30M(-8.9%)
$1.50B(-0.4%)
Jun 2005
-
$422.90M(+39.7%)
$1.50B(+13.3%)
Mar 2005
-
$302.70M(-21.2%)
$1.32B(+6.3%)
Dec 2004
$1.25B(+98.9%)
$384.10M(-1.9%)
$1.25B(+18.8%)
Sep 2004
-
$391.40M(+58.6%)
$1.05B(+31.8%)
Jun 2004
-
$246.80M(+10.3%)
$795.40M(+23.0%)
Mar 2004
-
$223.70M(+19.9%)
$646.70M(+3.2%)
Dec 2003
$626.60M(+77.2%)
$186.50M(+34.8%)
$626.60M(+33.8%)
Sep 2003
-
$138.40M(+41.1%)
$468.40M(+10.9%)
Jun 2003
-
$98.10M(-51.8%)
$422.40M(-7.0%)
Mar 2003
-
$203.60M(+619.4%)
$454.30M(+28.4%)
Dec 2002
$353.70M(+29.5%)
$28.30M(-69.4%)
$353.70M(-5.9%)
Sep 2002
-
$92.40M(-28.9%)
$375.75M(+7.5%)
Jun 2002
-
$130.00M(+26.2%)
$349.46M(+20.8%)
Mar 2002
-
$103.00M(+104.6%)
$289.18M(+5.9%)
Dec 2001
$273.15M(+64.9%)
$50.35M(-23.8%)
$273.15M(+22.6%)
Sep 2001
-
$66.12M(-5.2%)
$222.80M(+42.2%)
Jun 2001
-
$69.71M(-19.8%)
$156.68M(+80.2%)
Mar 2001
-
$86.97M
$86.97M
Dec 2000
$165.63M(+6.8%)
-
-
Dec 1999
$155.06M(+113.2%)
-
-
Dec 1998
$72.71M(-62.4%)
-
-
Dec 1997
$193.60M(-2947.1%)
-
-
Dec 1996
-$6.80M(-106.4%)
-
-
Dec 1995
$106.30M(+135.2%)
-
-
Dec 1994
$45.20M(+24.2%)
-
-
Dec 1993
$36.40M(+37.9%)
-
-
Dec 1992
$26.40M(+190.1%)
-
-
Dec 1991
$9.10M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cash flow from operations?
  • What is the all time high annual CFO for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual CFO year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly CFO year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cash flow from operations?
  • What is the all time high TTM CFO for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM CFO year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cash flow from operations?

The current annual CFO of TEVA is $1.25B

What is the all time high annual CFO for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cash flow from operations is $5.54B

What is Teva Pharmaceutical Industries Limited annual CFO year-on-year change?

Over the past year, TEVA annual cash flow from operations has changed by -$121.00M (-8.85%)

What is Teva Pharmaceutical Industries Limited quarterly cash flow from operations?

The current quarterly CFO of TEVA is -$105.00M

What is the all time high quarterly CFO for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from operations is $1.75B

What is Teva Pharmaceutical Industries Limited quarterly CFO year-on-year change?

Over the past year, TEVA quarterly cash flow from operations has changed by +$19.00M (+15.32%)

What is Teva Pharmaceutical Industries Limited TTM cash flow from operations?

The current TTM CFO of TEVA is $1.27B

What is the all time high TTM CFO for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cash flow from operations is $6.01B

What is Teva Pharmaceutical Industries Limited TTM CFO year-on-year change?

Over the past year, TEVA TTM cash flow from operations has changed by -$123.00M (-8.86%)
On this page